45
Views
9
CrossRef citations to date
0
Altmetric
Editorial

The menopause transition: the next neuroendocrine frontier

, &
Pages S7-S10 | Published online: 09 Jan 2014
 

Financial disclosure

This work was written as part of Veronica Harsh’s official duties as a US Government employee. The views expressed in this article do not necessarily represent the views of the NIMH, NIH, HHS, or the United States Government. The authors have no relevant financial interests including employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties related to this manuscript.

Drs Schmidt and Harsh receive material support for their research from Watson Pharmaceuticals in the form of estradiol and placebo patches.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.